Abstract
Lung volume reduction surgery (LVRS) is a viable option for a select group of emphysema patients. Effective preoperative pulmonary rehabilitation and careful patient selection criteria promote favorable outcomes. Effective perioperative pain management and early extubation are significant factors that minimize postoperative complications and lead to better outcome. LVRS improves dyspnea and exercise tolerance and increases potential for patient survival in appropriately selected patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Prevalence and incidence of chronic obstructive pulmonary disease. 2010. http://www.cureresearch.com/c/copd/prevalence.html. Accessed 24 Jan 2010.
Brantigan OC, Mueller E, Kress MB. A surgical approach to pulmonary emphysema. Am Rev Respir Dis. 1959;80(1 Pt. 2):194–206.
Cooper JD, Lefrak SS. Is volume reduction surgery appropriate in the treatment of emphysema? Yes. Am J Respir Crit Care Med. 1996;153:1201–4.
McKenna RJ Jr, Benditt JO, DeCamp M, et al. Safety and efficacy of median sternotomy versus video-assisted thoracic surgery for lung volume reduction surgery. J Thorac Cardiovasc Surg. 2004;127:1350–60.
National Emphysema Treatment Trial Group. Rationale and design of the national emphysema treatment trial (NETT): a prospective randomized trial of lung volume reduction surgery. J Thorac Cardiovasc Surg. 1999;118:518–28.
Carrell RW, Jeppsson JO, Laurell CB, et al. Structure and variation of the human alpha-1-antitrypsin. Nature. 1982;298:329–34.
Janus ED, Phillips NT, Carrell RW. Smoking, lung function and alpha-1-antitrypsin deficiency. Lancet. 1985;1:152–4.
Potter WA, Olafsson S, Hyatt RE. Ventilatory mechanics and expiratory flow limitation during exercise in patients with obstructive lung disease. J Clin Invest. 1971;50:910–9.
Stubbing DC, Pengelly LD, Morse JLC, et al. Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol. 1980;49:511–5.
American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis. 1987;136:225–44.
Buist AS, Sexton GJ, Nagy JM, Ross BB. The effect of smoking cessation and modification on lung function. Am Rev Respir Dis. 1976;114:115–22.
Cooper JD, Trulock EP, Triantafillou AN, et al. Bilateral pneumectomy volume reduction for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg. 1995;109:106–19.
Hughes RL, Davison R. Limitations of exercise reconditioning in COPD. Chest. 1983;83:241–9.
Sahn SA. Corticosteroid therapy in chronic obstructive pulmonary disease. Pract Cardiol. 1985;11(8):150–6.
Tager I, Speizer FE. Role of infection in chronic bronchitis. N Engl J Med. 1975;292:563–71.
Anthonisen NR. Long-term oxygen therapy. Ann Intern Med. 1983;99:519–27.
Nocturnal Oxygen Therapy Trail Group. Continuous or nocturnal oxygen therapy in hypoxemia chronic obstructive lung disease: a clinical trial. Ann Intern Med. 1980;91:391–8.
Tuxen DV, Lane S. The effects of ventilatory pattern on hyperinflation, airway pressures, and circulation in mechanical ventilation of patients with severe air-flow obstruction. Am Rev Respir Dis. 1987;136:872–9.
Weinmann GG, Hyatt R. Evaluation and research in lung volume reduction surgery. Am J Respir Crit Care Med. 1996;154:1913–8.
Daniel TM, Barry BK, Chan MD, et al. Lung volume reduction surgery: case selection, operative technique, and clinical results. Ann Surg. 1996;223(5):526–33.
Wisser W, Klepetko W, Senbaklavaci O, et al. Chronic hypercapnia should not exclude patients from lung volume reduction surgery. Eur J Cardiothorac Surg. 1998;14:107–12.
Thurnheer R, Muntwyler J, Stammberger U, et al. Coronary artery disease in patients undergoing lung volume reduction surgery for emphysema. Chest. 1997;112(1):122–8.
Hamacher J, Block KE, Stammberger U, et al. Two years’ outcome of lung volume reduction surgery in different morphologic emphysema types. Ann Thorac Surg. 1999;68:1792–8.
Rogers RM, Coxson HO, Sciurba FC, et al. Preoperative severity of emphysema predictive of improvement after lung volume reduction surgery – use of CT morphometry. Chest. 2000;118:1240–7.
Salzman SH. Can CT measurement of emphysema severity aid patient selection for lung volume reduction surgery? Chest. 2000;118:1231–2.
Thurnheer R, Engel H, Weder W, et al. Role of lung perfusion scintigraphy in relation to chest computed tomography and pulmonary function in the evaluation of candidates for lung volume reduction surgery. Am J Respir Crit Care Med. 1999;159(1):301–10.
National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med. 2001;345(15):1075–83.
Dueck R, Cooper S, Kapelanski D, Colt H, Clauser J. A pilot study of expiratory flow limitation and lung volume reduction surgery. Chest. 1999;116:1762–71.
Gelb AF, Zamel N, McKenna RJ, Brenner M. Mechanism of short-term improvement in lung function after emphysema resection. Am J Respir Crit Care Med. 1996;154:945–51.
Marchand E, Gayan-Ramirez G, De Leyn P, Decramer M. Physiological basis of improvement after lung volume reduction surgery for severe emphysema: where are we? Eur Respir J. 1999;13(3):686–96.
Sciurba FC, Rogers RM, Keenan RJ, Slivka WA, Gorcsan J, Ferson PF, Holbert JM, Brown ML, Landreneau RJ. Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med. 1996;334:1095–9.
Tschernko EM, Wisser W, Hofer S, et al. Influence of lung volume reduction on ventilatory mechanics in patients suffering from severe COPD. Anesth Analg. 1996;83:996–1001.
Ingenito EP, Evans RB, Loring SH, et al. Relation between preoperative inspiratory lung resistance and the outcome of lung-volume-reduction surgery for emphysema. N Engl J Med. 1998;338:1181–5.
Tschernko EM, Kritzinger M, Gruber EM, et al. Lung volume reduction surgery: preoperative functional predictors for postoperative outcome. Anesth Analg. 1999;88:28–33.
Tutic M, Lardinois D, Imfeld S, et al. Lung – volume reduction surgery as an alternative or bridging procedure to lung transplantation. Ann Thorac Surg. 2006;82:208–13.
The National Emphysema Treatment Trial Research Group. Effects of lung volume reduction surgery versus medical therapy: results from the National Emphysema Treatment Trial. N Engl J Med. 2003;324:2059–73.
Naunheim KS, Wood DE, Mohnsenifar Z, et al. Long-term follow-up of patients receiving lung-volume reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg. 2006;82:431–3.
Toma TP, Hopkinson NS, Hillier J, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet. 2003;361:931–3.
Yim AP, Hwong TM, Lee TW, et al. Early results of endoscopic lung volume reduction for emphysema. J Thorac Cardiovasc Surg. 2004;127:1564–73.
Salanitri J, Kalff V, Kelly M, et al. 133Xenon ventilation scintigraphy applied to bronchoscopic lung volume reduction techniques for emphysema: relevance of interlobar collaterals. Int Med J. 2005;35:97–103.
Reilly J, Washko G, Pinto-Plata V, et al. Biological lung volume reduction: a new bronchoscopic therapy for advanced emphysema. Chest. 2007;131:1108–13.
Shah PL, van Geffen WH, Desiee G, Slebos D-J. Lung volume reduction for emphysema. Lancet Respir Med. 2017;5:147–56.
Weinberg M, Hendeles L. Methylxanthines. In: Weiss EB, Segal MS, Stein M, editors. Bronchial asthma. Mechanisms and therapeutics. 2nd ed. Boston: Little Brown and Company; 1985.
Ballantyne JC, Carr DB, deFerranti S, et al. The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials. Anesth Analg. 1998;86(3):598–612.
Warner DO. Preventing postoperative pulmonary complications. Anesthesiology. 2000;92:1467–72.
Keenan DJM, Cave K, Langdon L, et al. Comparative trial of rectal indomethacin and cryoanalgesia for control of early postthoracotomy pain. Br Med J. 1983;287:1335.
Karmakar MJ. Thoracic paravertebral block. Anesthesiology. 2001;95:771–80.
Hill SE, Keller RA, Stafford-Smith M, et al. Efficacy of single-dose, multilevel paravertebral nerve blockade for analgesia after thoracoscopic procedures. Anesthesiology. 2006;104:1047–53.
Loehning RW, Waltemath CL, Bergman NA. Lidocaine and increased respiratory resistance produced by ultrasonic aerosols. Anesthesiology. 1976;44:306–10.
Brandus V, Joffe S, Benoit CV, et al. Bronchial spasm during general anesthesia. Can Anesth Soc J. 1970;17:269–74.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Clinical Case Discussion
Clinical Case Discussion
Case: A 58-year-old female patient with end-stage emphysema is scheduled for bilateral LVRS using a video-assisted thoracoscopic approach (VATS). She has a past medical history that is significant for smoking (60 pack years; quit for the past 2 years), hypertension, and atrial fibrillation that is controlled with metoprolol. Her other medication includes an 81-mg aspirin that she takes once per day. She successfully completed a preoperative exercise program 8 weeks ago. The patient is very anxious and wishes to speak with the anesthesiologist who will provide her care prior to the date of surgery.
Questions
-
What additional preoperative preparation is necessary from a pulmonary standpoint?
-
How will you treat the patient’s anxiety?
-
What will you recommend for perioperative pain management?
-
What are your specific concerns regarding postoperative management?
Preoperative Pulmonary Preparation
-
Successful completion of a preoperative exercise program including a 6-min walk on a flat surface, bicycle ergometer, and weight lifting (see section “Preoperative Medical Management of Emphysema Patients”).
-
Continue supplemental oxygen use, bronchodilators, and mucolytics up to and including the day of surgery (see section “Pharmacologic Preparation”).
-
Gradually reduce the dose of steroids prior to surgery if they are being administered.
-
If the patient is receiving theophylline therapy and exhibiting symptoms of toxicity (nervousness, tremor, tachycardia) or if serum levels exceed 20 ng/mL, discontinue the drug.
-
Ensure that the patient is free from infection and does not require antibiotics for at least a 3-week period prior to surgery.
Treatment of Anxiety
-
Untreated anxiety may precipitate an episode of acute bronchospasm, an increase in dynamic pulmonary hyperinflation, and dyspnea (see section “Preoperative Medical Management of Emphysema Patients”).
-
An effective way to allay a patient’s anxiety is for the anesthesiologist to establish a good relationship with the patient prior to the date of surgery by scheduling a meeting in the anesthesia preoperative evaluation clinic.
-
Anxiolytic therapy may be necessary during the preoperative and perioperative period.
Perioperative Analgesia
-
The patient is at high risk for perioperative pulmonary complications if analgesia is insufficient or ineffective.
-
The risk of pulmonary complications may be improved with the use of thoracic epidural or paravertebral analgesia (see sections “Thoracic Epidural Analgesia” and “Paravertebral Nerve Block”).
-
TEA or paravertebral nerve block catheters should be maintained until the chest drains are removed and the patient is tolerating oral pain medications.
Postoperative Management (see sections “Early Extubation” and “Postoperative Management”)
-
Air leakage can be exacerbated by positive pressure ventilation. Therefore, the patient should be extubated as soon as it is safe to do so, preferably in the operating room. It is safe, however, to maintain mechanical ventilation for 1–2 h following surgery, and this is preferable to premature extubation and the subsequent development of arterial hypoxemia.
-
Fifty percent of LVRS patients develop a postoperative complication.
-
Reintubation and mechanical ventilation in the postoperative period are associated with a high morbidity and mortality.
-
Postoperative complications can be minimized by implementing judicious pulmonary toilet, bronchodilator therapy, effective pain management with thoracic epidural or paravertebral analgesia, and avoidance of systemic corticosteroids.
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sullivan, E.A. (2019). Lung Volume Reduction. In: Slinger, P. (eds) Principles and Practice of Anesthesia for Thoracic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-00859-8_46
Download citation
DOI: https://doi.org/10.1007/978-3-030-00859-8_46
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-00858-1
Online ISBN: 978-3-030-00859-8
eBook Packages: MedicineMedicine (R0)